CLASS II Device recall · Reported 19 Apr 2017 · FDA Enforcement Report
Delta XL recalled by Draegar Medical Systems
Draegar Medical Systems is recalling Delta XL, distributed nationwide in the US. The recall was initiated on 28 Mar 2017 and the FDA has classified it as Class II.
Check your package
Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.
Recall details
- Recall number
- Z-1773-2017
- FDA event ID
- 76862
- Recalling firm
- Draegar Medical Systems, Andover, MA
- Classification
- Class II
- Status
- Terminated
- Recall initiated
- 28 Mar 2017
- FDA classified
- 10 Apr 2017
- Reported
- 19 Apr 2017
- Type
- Voluntary: Firm initiated
- Customers notified by
- Letter
- Reason category
- Device Malfunction
- Device type
- Patient Monitors
Timeline
| 28 Mar 2017 | Recall initiated by company | |
| 10 Apr 2017 | Classified by FDA | +13 days |
| 19 Apr 2017 | Published in enforcement report | +9 days |
Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.
Reason for recall
It was reported that a set low O2 alarm does not go off although the measured O2 level is below the alarm limit.
Device recalls are issued when a component, software or design fault could cause the device to fail or give wrong readings. Many are corrections applied in the field rather than physical returns.
Product as listed by the FDA
Delta XL, Catalog Number: MS18596 in combination with Scio, Scio Four, Scio Four Oxi plus, Scio Four Oxi, Scio Four plus. Product Usage: The devices are intended to be used in the environment where patient care is provided by Healthcare Professionals, i.e. Physicians, Nurses, and Technicians, who will determine when use of the device is indicated, based upon their professional assessment of the patients medical condition. The Infinity Delta Series (Delta/Delta XL/Kappa) monitors are intended to be used on adult, pediatric, and neonatal populations, with the exception of the parameter Cardiac Output, ST Segment Analysis, and arrhythmia which are intended for use in the adult and pediatric populations only; and tcpO2, which for the neonatal population, is to only be used when the patient is not under gas anesthesia. For combination with Scio gas module: Scio gas module samples breathing gases from adults and pediatrics. The gas module continuously measure the content of CO2, N2O, O2 and one of the anesthetic agents, Halothane, Isoflurane, Enflurane, Sevoflurane and Desflurane in any mixture and communicates real time and derived gas information to the In-finity monitors.
Where it was distributed
Worldwide - US Nationwide distribution in the states of: AL, CA, GA, IL, LA, MA NY, OH, PA, TN, TX and VA and the countries of: AR AT BE BG BN BO BY CA CH CL CO CZ DE EG ES FI FR GB GR HR HU ID IE IL IN IT LT MX MY NL NO NP PA PE PK PL PT RO RS RU SA SE SK TH TR TW UG UZ VN ZA
Nationwide AlabamaArkansasCaliforniaColoradoGeorgiaIllinoisLouisianaMassachusettsNew YorkOhioPennsylvaniaTennesseeTexasVirginia
Questions about this recall
Is Delta XL recalled?
Yes. Draegar Medical Systems recalled Delta XL on 28 Mar 2017. The recall is Class II and its status is Terminated. Recall number Z-1773-2017.
Why was it recalled?
It was reported that a set low O2 alarm does not go off although the measured O2 level is below the alarm limit.
Which lots are affected?
VF10.0 software
Where was it sold?
Worldwide - US Nationwide distribution in the states of: AL, CA, GA, IL, LA, MA NY, OH, PA, TN, TX and VA and the countries of: AR AT BE BG BN BO BY CA CH CL CO CZ DE EG ES FI FR GB GR HR HU ID IE IL IN IT LT MX MY NL NO NP PA PE PK PL PT RO RS RU SA SE SK TH TR TW UG UZ VN ZA
What should I do if I have it?
Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.
What does Class II mean?
Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.
Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.
More recalls from Draegar Medical Systems
All 13| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Device | CLASS II | Drager Infinity CentralStation recalled by Draegar Medical Systems | Draegar Medical Systems | Device Malfunction | Nationwide |
| Device | CLASS II | Infinity Acute Care System (Iacs) Monitoring Solution recalled | Draegar Medical Systems | Other | Nationwide |
| Device | CLASS II | Infinity M300 telemetry monitoring device recalled | Draegar Medical Systems | Device Malfunction | Nationwide |
| Device | CLASS II | The Infinity Acute Care System recalled by Draegar Medical Systems | Draegar Medical Systems | Device Malfunction | Nationwide |
| Device | CLASS II | Omega Systems These devices are intended to be used recalled | Draegar Medical Systems | Device Malfunction | Nationwide |
Other Patient Monitors recalls
All 1,013| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Device | CLASS I | Bravo CF capsule delivery device, Product Number FGS recalled | Given Imaging | Device Malfunction | Nationwide |
| Device | CLASS II | Lux-Dx, Lux-Dx II, Lux-Dx II+ Insertable Cardiac Monitor recalled | Boston Scientific | Device Malfunction | Nationwide |
| Device | CLASS II | Lux-Dx, Lux-Dx II, Lux-Dx II+ Insertable Cardiac Monitor recalled | Boston Scientific | Device Malfunction | Nationwide |
| Device | CLASS II | Lux-Dx, Lux-Dx II, Lux-Dx II+ Insertable Cardiac Monitor recalled | Boston Scientific | Device Malfunction | Nationwide |
| Device | CLASS II | IQecg Digital ECG recalled by Midmark | Midmark | Labeling Errors | Nationwide |